Food as Medicine Market
Food as Medicine Market By Product Type (Functional Foods, Medical Foods, Nutraceuticals, Personalized Nutrition Products, Therapeutic Food Products), Function (Metabolic Health, Diabetes Management, Cardiovascular Health, Gastrointestinal Health, Immune Health, Other Functions), Ingredient Type, Source, Form, Distribution Channel, Prescription Type (Qualitative), and Region – Global Forecast to 2031
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The food as medicine market is projected to reach USD 400.81 billion by 2031 from USD 254.15 billion in 2026, at a CAGR of 9.5% from 2026 to 2031. Growing consumer preference for preventive healthcare and wellness-focused lifestyles is increasing the adoption of nutrition-based health solutions. Increasing awareness of the role of nutrition in disease management and overall wellness is further driving demand for functional foods and medical nutrition products.
KEY TAKEAWAYS
-
BY REGIONThe Asia Pacific region is estimated to account for the largest share (26.8%) of the food as medicine market in 2026.
-
BY PRODUCT TYPEBy product type, the functional food segment is estimated to lead the market with a share of 37.7% in 2026
-
BY FUNCTIONBy function, the cognitive & mental health segment is projected to witness the highest CAGR of 13.6% from 2026 to 2031.
-
BY FORMBy form, the solid segment is expected to hold a dominant market share during the forecast period.
-
COMPETITIVE LANDSCAPE - KEY PLAYERSNestlé Health Science (Switzerland), Danone (France), and Abbott Nutrition (US) were identified as some of the star players in the food as medicine market (global), given their global presence and strong product footprint.
-
COMPETITIVE LANDSCAPE - STARTUPS/SMEsZOE (UK), Kapiva (India), and Seed Health (US), among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The food as medicine market is experiencing substantial growth. This is primarily driven by the rising prevalence of chronic diseases, increasing consumer focus on preventive healthcare, and growing adoption of personalized nutrition and functional foods. Expanding use of medically tailored meals and medical nutrition products, and greater integration of nutrition-based interventions across healthcare systems worldwide, are further accelerating market growth.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
Customer business in the food as medicine market is driven by rising demand for personalized nutrition, preventive healthcare, and functional foods. These trends are expanding innovative nutrition solutions and creating growth opportunities across the healthcare and nutrition industries.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Expansion of personalized nutrition and precision health solutions
-
Growing demand for gut health, immune health, and healthy aging products
Level
-
High cost of specialized medical nutrition and personalized nutrition products
-
Lack of standardized regulations across countries
Level
-
Advancements in personalized nutrition, nutrigenomics, and microbiome science
-
Growing healthcare expenditure and awareness of nutrition-based disease management
Level
-
High costs associated with clinical trials and scientific validation
-
Supply chain disruptions affecting specialty ingredients and bioactive compounds
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Expansion of personalized nutrition and precision health solutions
Growing consumer demand for tailored dietary interventions is accelerating the adoption of personalized nutrition products. Advances in health data analytics and biomarker-based nutrition are further supporting market growth.
Restraint: High cost of specialized medical nutrition and personalized nutrition products
Premium pricing of personalized nutrition programs and medical foods limits accessibility for many consumers. High production and customization costs remain a barrier to widespread adoption.
Opportunity: Advancements in personalized nutrition, nutrigenomics, and microbiome science
Innovations in nutrigenomics and microbiome research are enabling more targeted and effective nutrition solutions. These developments are creating new opportunities for food as medicine product innovation and market expansion.
Challenge: High costs associated with clinical trials and scientific validation
Demonstrating the efficacy of food as medicine requires extensive clinical research and regulatory validation. The associated costs and lengthy timelines can slow product development and commercialization.
FOOD AS MEDICINE MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Expanded its specialized nutrition portfolio through products such as Fortimel and disease-specific medical nutrition offerings designed for malnutrition and clinical nutrition support. | Improves patient nutritional outcomes, supports recovery, and addresses disease-related malnutrition. |
 |
Developed Glucerna, a nutrition solution formulated for people with diabetes to help manage blood glucose response. | Supports diabetes management, glycemic control, and balanced nutrition. |
 |
Commercialized Yakult probiotic beverages containing Lacticaseibacillus casei Shirota to support gut microbiome health. | Improves digestive health, supports immune function, and promotes gut microbiota balance. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The food and medicine market ecosystem is categorized into food and medicine manufacturers, regulatory bodies, startups and SMEs, and distributors. The market is a rapidly growing ecosystem driven by personalized nutrition, preventive healthcare, and functional food solutions. Established companies and innovative startups are developing science-backed products to improve health and wellness outcomes.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Food as Medicine Market, By Product Type
The functional foods segment is estimated to hold the largest market share due to growing demand for healthy, nutrient-rich foods that support daily wellness and preventive health.
Food as Medicine Market, By Source
The plant-based segment is estimated to lead the market as consumers increasingly prefer natural, sustainable, and clean-label nutrition products.
Food as Medicine Market, By Form
The solid segment is estimated to dominate the market as solid forms are convenient, easy to consume, and widely available as bars, powders, capsules, and fortified foods.
Food as Medicine Market, By Ingredient Type
The proteins & amino acids segment is estimated to lead the market due to their wide use in functional foods, medical nutrition, and wellness products.
REGION
Asia Pacific to dominate global agricultural calcium market
The North America is estimated to dominate the global gelatin market. The significant market share is mainly attributed to the region's advanced healthcare infrastructure, strong presence of leading nutrition and wellness companies, increasing adoption of personalized nutrition and functional foods, and growing consumer focus on preventive healthcare and healthy living.
FOOD AS MEDICINE MARKET: COMPANY EVALUATION MATRIX
In the gelatin market matrix, Danone (France) (Star) lead with a moderate market share and extensive product portfolios, driven by their strong global presence, strong global footprint, advanced processing capabilities, diversified application offerings, and continuous investments in innovation. Reckitt Mead Johnson (UK),(Emerging Leader) gaining visibility through specialized and cost-efficient food as medicine solutions, strengthening their market position through innovation and expanding regional reach.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Nestlé Health Science (Switzerland)
- Danone (France)
- Abbott Nutrition (US)
- Novonesis (Denmark)
- Amway (US)
- Herbalife (US)
- FrieslandCampina (Netherlands)
- Yakult Honsha Co., Ltd. (Japan)
- Reckitt Mead Johnson (UK)
- Herbalife (US)
- Unilever (UK)
- Otsuka Holdings (Japan)
- Probi AB (Sweden)
- Church & Dwight Co., Inc. (US)
- Meiji Holdings (Japan)
- Jamieson Wellness (Canada)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2026 (Value) | USD 254.15 BN |
| Market Forecast in 2031 (Value) | USD 400.81 BN |
| Growth Rate | CAGR of 9.5% from 2026 to 2031 |
| Years Considered | 2022–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Billion), Volume (KT) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, South America, Rest of the World |
WHAT IS IN IT FOR YOU: FOOD AS MEDICINE MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| North America-based food as medicne manufacturers |
|
|
| Food as medicine segment assessment |
|
|
RECENT DEVELOPMENTS
- June 2026 : Danone announced the acquisition of MADE Group, an Australian health food company known for high protein, gut health, and plant based nutrition brands. The deal strengthens Danone’s healthy nutrition portfolio in the Asia Pacific region and supports its strategy to expand in fast-growing health and wellness food categories.
- March 2026 : Meiji launched enhanced Meiji Step and Meiji Step Raku Raku Cube follow-up milk products containing Bifidobacterium OLB6378 and zinc to support gut health, immunity, and healthy development in children aged 1 to 3 years
- May 2024 : Nestlé launched Vital Pursuit, a new brand of high protein, nutrient dense, and fiber rich meals specifically designed to support consumers using GLP 1 weight loss medications. The product range aims to address nutritional needs during weight management while promoting muscle maintenance and overall wellness.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This study employed two primary approaches to estimate the current size of the food as medicine market. Exhaustive secondary research was carried out to collect information on the source, product type, ingredient type, function, form, distribution channel, prescription type, and regional segments of the market. The next step involved validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, data triangulation was used to estimate the market size of segments and subsegments.
Secondary Research
This research study used extensive secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information for a technical, market-oriented, and commercial market study. In the secondary research process, sources such as annual reports, press releases & investor presentations of companies, white papers, agriculture and food as medicine-related journals, certified publications, articles from recognized authors, directories, and databases were referred to to identify and collect information. Secondary research was mainly used to obtain key information about the industry’s supply chain, the pool of key players, and market classification and segmentation based on the industry trends to the bottom-most level, regional markets, and key developments from market- and technology-oriented perspectives.
Primary Research
Extensive primary research was conducted after obtaining information regarding the food as medicine market scenario through secondary research. Several primary interviews were conducted with market experts from the demand and supply sides. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as chief experience officers (CXOs), vice presidents (VPs), directors from business development, marketing, research, and development teams, and related key executives from distributors and key opinion leaders.
Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to the food as medicine market segments, including source, product type, ingredient type, function, form, distribution channel, prescription type, and region. Stakeholders from the demand side, including hospitals and healthcare institutions, clinical nutrition providers, functional food manufacturers, medical food producers, nutraceutical companies, personalized nutrition providers, retail and e-commerce distributors, and wellness organizations, were interviewed to understand buyers' perspectives on suppliers, product requirements, purchasing trends, adoption of nutrition-based healthcare solutions, and the future outlook of the food as medicine market.
Note: The three tiers of the companies are defined based94945332on their total revenues, based on the availability of financial data: Tier 1: Revenue >USD 1 billion; Tier 2: USD 100 million ≤ revenue ≤ USD 1 billion; Tier 3: Revenue USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
|
COMPANY |
DESIGNATION |
|
Herbalife (US) |
Regional Sales Manager |
|
Novonesis (Denmark) |
Marketing Manager |
|
Abbott Nutrition (US) |
General Manager |
|
Nestlé Health Science (Switzerland) |
Sales Manager |
|
Danone (France) |
Sales Manager |
|
Yakult Honsha Co., Ltd. (Japan) |
Sales Executive |
Market Size Estimation
The top-down and bottom-up approaches were used to estimate and validate the total size of the food as medicine market. These approaches were also used extensively to determine the size of various subsegments in the market. The research methodology used to estimate the market size includes the following details:
- The key players in the industry and the overall market were identified through extensive secondary research.
- All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
- All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.
- The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.
Data Triangulation
After determining the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to estimate the overall food as medicine market and obtain precise statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using the top-down and bottom-up approaches.
Market Definition
The food as medicine market comprises functional foods, medical foods, nutraceuticals, personalized nutrition products, and therapeutic foods that are specifically formulated to support disease prevention, health management, and overall wellness through targeted nutritional interventions. These products contain scientifically validated ingredients such as probiotics, prebiotics, dietary fibers, proteins, vitamins, minerals, and bioactive compounds that provide health benefits beyond basic nutrition.
The market is driven by the rising prevalence of chronic diseases, growing consumer awareness of preventive healthcare, and increasing demand for personalized and evidence-based nutrition solutions. Advancements in microbiome research, nutrigenomics, and precision nutrition technologies, along with supportive healthcare initiatives and increasing health-consciousness among consumers, continue to accelerate the adoption of food as medicine products worldwide.
Key Stakeholders
- Supply-side: Food as medicine product manufacturers, functional food producers, medical food manufacturers, nutraceutical companies, personalized nutrition providers, ingredient suppliers, probiotic and prebiotic producers, bioactive ingredient manufacturers, contract manufacturing organizations (CMOs), and distribution partners.
- Processing and product manufacturers: Functional food and beverage manufacturers, medical nutrition companies, nutraceutical supplement manufacturers, personalized nutrition companies, dairy and fermented food producers, therapeutic food manufacturers, and clinical nutrition product developers utilizing food as medicine ingredients in their formulations.
- Demand-side: Hospitals and healthcare institutions, clinical nutrition providers, dietitians and nutritionists, pharmacies, retail and e-commerce channels, wellness centers, disease management programs, consumers seeking preventive healthcare solutions, and long-term care facilities requiring nutrition-based interventions.
- Regulatory side: Food and nutrition regulatory authorities, healthcare agencies, food safety organizations, clinical nutrition regulatory bodies, quality assurance organizations, and standards agencies overseeing product safety, efficacy, labeling, health claims, and manufacturing compliance.
-
Associations and industry bodies:
- European Food Safety Authority (EFSA)
- World Health Organization (WHO)
- US Food and Drug Administration (USFDA)
- Food Safety and Standards Authority of India (FSSAI)
- Food and Agriculture Organization (FAO)
- Council for Responsible Nutrition (CRN)
- American Society for Nutrition (ASN)
- National Institutes of Health (NIH)
- International Probiotics Association (IPA)
Report Objectives
- To determine and project the size of the food as medicine market based on product type, source, function, ingredient type, form, distribution channel, prescription type, and region over the forecast period
- To identify key growth opportunities by analyzing the largest and fastest-growing segments across regions
- To provide detailed insights on factors influencing market growth, including drivers, restraints, opportunities, and challenges
- To evaluate market opportunities for stakeholders and present the competitive landscape of leading players
- To analyze micro-markets with respect to individual growth trends, future potential, and their contribution to the overall market
- To identify and profile key companies operating in the market
- To assess the competitive environment and highlight key strategies adopted by major players across regions
Customization Options :
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolio of each company.
Segmental Analysis
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
- Further breakdown of the Rest of Europe food as medicine market into key countries
- Further breakdown of the Rest of Asia Pacific food as medicine market into key countries
- Further breakdown of the Rest of South America food as medicine market into key countries
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Food as Medicine Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
Business Innovation Director
US Based Leading Agribusiness,
Food and Ingredients ManufacturerI highly appreciate the team's efficiency for a well conducted study that helped us clarify some blind spots in food and agricultural niche markets. Although compiling information for B2B markets is very difficult, the MnM team pulled out the task successfully. The quality of research, level of insights, and responsiveness of team were commendable.
Growth opportunities and latent adjacency in Food as Medicine Market